All second-generation CAR-T cells specifically killed VEGFR2-expressing tumor cells, but their cytotoxic activity according to the effector cell to target cell (E/T) ratio differed greatly depending on the type of co-stimulatory molecule inserted as the 2nd STD (Figure 2C). The gene discussed is KDR; the disease is neoplasm.